A Fair Criticism Deserves a Response

Subscriber jryan (below) delivered some reasonable comments and criticism yesterday in the Comments Section. 

Basically he said he is “getting sick of reading about cannabis and Fin TV commentary” — and he wants more (long) stock suggestions, etc.  

I wanted to respond in the first column of the day. 

* Few longs have represented value to me as I have been unduly negative for a lengthy period of time. I take ownership of that.

* The stocks that I have owned have recently been Staples ($KO, $PEP, $PG and $KMB), selected cannabis names and some others. The consumer nondurable stocks have been fine recently (and I have taken profits in them). We shall see about cannabis — a speculative sector and my focus has been intermediate-term based on the improved likelihood of rescheduling and other factors clearly delineated in my Diary.

*As to the CNBC constructive criticism. I point these out not only as an advocate of the retail viewer that should see timestamps (panelists taking ownership) and observe better company interviews, but so they can evaluate the merits and process of the panelists’ recommendations and become better-informed investors through more hard-hitting interviews (that serve more than as a marketing tool of companies). 

* But the criticism directed to Fin TV also is intended to highlight investment recommendations from panelists and guests that I strongly disagree with. Choosing stocks to avoid (in that FIN TV criticism) can be as valuable or even more valuable than choosing stocks to buy. Consider my negative comments towards $BA, $BABA, $META, $UBER, $NFLX, $RDDT, $TTAN, $DIS, $CLF, $MRNA and $UNH (a few years back) etc. that were mostly confidently and strenuously recommended on CNBC. 

* My “More Tales From Nvidia” series is intended to deliver the idea that the functionality, productivity and ROIC on the enormous capital spend may disappoint the many and multitude of optimists on AI. I have felt that my contrarian and non herd-like observations were valuable in a backdrop of near-universal bullishness (that is readily and frequently available from the buy/sell sides, panelists and guests). My view was that dwelling on “More Tales” had statistical value in that over 40% of the S&P is comprised of large-cap tech.   

* As to specific AI beneficiaries, I have admitted (often) of missing $MSFT and $GOOGL. The valuation on $AAPL seems foolish to me — the shares have prospered and I have been wrong.  But the others ($META, $AMZN and even $NVDA) have not set the world on fire this year. As to memory and chip stocks, they have been “the world’s fair” up until the summer but awful since late June. Not only do I think these companies are “overearning,” but the volatility is not for me and not consistent and doesn’t conform with my appetite for risk. 

*  The financial stocks were quite strong until early summer. I repeatedly cautioned not to embrace banks, brokers and private equity shares (I successfully shorted $BX, $KKR and $APOL since then). Viewed by panelists as perhaps the best “value play,” financials have been dismal over the last four months.  We avoided this decline (in $C, $JPM, $BAC, $GS, $MS et al).

* The stocks that I have been short in the AI sphere have been terrific (to the downside) — $ORCL and $CRWV. (Avoiding them as longs has also been a valuable contribution.) My recent foray into shorting NVDA was profitable also. 

* As to my preoccupation with CNBC I suggest taking the number of words written about FIN TV and divide it by the number of words written on other subjects daily. You will find my criticism is dwarfed by my other columns. In the scheme of things my criticism is de minimis. 

* Finally, to jryan I say there are many other contributors that actively recommend longs and provide a valuable service.

All this said I am imperfect.

I take ownership of my mistakes.

The transparency of my Diary exposes my blemishes. 

I believe jryan has some good points and I will purposefully look for more long ideas in the future. 

I truly appreciate jryan’s comments and I have tried to respond to his concerns:

jryan

Just a thought. There used to be a lot of different investment ideas, stock suggestions etc., but all it seems to be now is cannabis and CNBC commentary, which I don’t watch anyway. Kind of getting sick of it, especially the cannabis info, is it ever going to pay off? Likely, but it will be quite a while from today, if ever. But at least it’s easier to scroll through the commentary and use less time.

Position: Long KO (VS), PG (VS), KMB (VS), MSOS common (VL) and calls (VS), VRNO (VS), GLAS (S), GTBIF (S), TRLV (VS), CURLF (VS); Short AAPL (S)

Staples Are UnStable Today

*  This week I warned that it was ‘too much too fast’…

I further reduced my staples exposure recently — today we are seeing a lot more pressure on consumer non-durables (($PG) -$1,  ($PEP) -$3, ($KMB) -$1 and ($KO) -$1.25 (I warned about a sell off after the guide up).

From last week:

Staples Slammed

Staples (consumer non-durables) are getting hit over the last few hours.

A reminder, I am down to VS on KMB, PG and KO.

I sold out my entire PEP holdings.

I would be a buyer of the space on weakness — but not at current prices.

Position: Long KMB (VS), PG (VS), KO (VS)

Position: LONG KMB (VS), PG (VS) KO (VS)

P&G and My Staples Plays

Procter & Gamble’s ($PG) beat will likely help collateral staples plays like PepsiCo ($PEP), Coca-Cola ($KO) and Kimberly-Clark ($KMB).

Position: Long PG (VS), KO (VS), KMB (VS)

Staples Slammed

Staples (consumer non-durables) are getting hit over the last few hours.

A reminder, I am down to VS on $KMB, $PG and $KO.

I sold out my entire $PEP holdings.

I would be a buyer of the space on weakness — but not at current prices.

Position: Long KMB (VS), PG (VS), KO (VS)

Regrets I Have Had a Few… Recently

Regrets, I’ve had a few
But then again, too few to mention
I did what I had to do
And saw it through without exemption

I planned each charted course
Each careful step along the byway
And more, much, much more
I did it, I did it my way

– Frank Sinatra, My Way  Frank Sinatra – My Way | Live from The Main Event at Madison Square Garden (1974)

Few in the business take ownership of their losses and missed opportunities (long and short).

Every day I listen/view the B.S. of guests and panelists in the business media — as if they never made an investing or trading boner. Their insistence of buying lows and selling highs is disingenuous.

But I do take ownership of my screwups. 

As I have written, I am often wrong and always in doubt (and I mean that, as they are just not words).

Over the last four weeks I have had my share of blows — most recently in cannabis and Glass House ($GLAS) (which I will be discussing after speaking to management). After profiting and selling near the 52-week high, I sold my PepsiCo ($PEP) prematurely (after buying back near the 52-week low) — missing the last five-day advance from my sale price.

I failed to take advantage of excellent opportunities on the long side — specifically Microsoft ($MSFT) and Amazon ($AMZN), which I was poised to buy, but my ursine predilection held me back.

I also failed to take advantage of the opportunity set of individual short names. I saw “no broadening” and I took a quick and profitable trade shorting the Russell Index ($IWM) right at the highs, but I missed the big move (from $305 to under $280). I took a series of short-term gains in trading $SPY and $QQQ but missed the big (and playable) move down in the Nasdaq.

So…

My national anthem… but you need not rise!

My friends I have made it clear and I have stated my (bearish) case of which I am certain.

I have travelled each and every highway.

But more, more than this I did it my way.

Regrets I have had a few recently.

I grew tall through it all and did it my way.

I’ve loved, laughed and cried

I had my fill, my share of losing.

And now, as the tears subside.

I still don’t find that it’s all so amusing.

I took the blows but did it my way.

Position: Long GLAS (S)

The Fall of 2026 Is Starting to Resemble the Spring of 2000

* But there are important differences which will likely produce more muted downside to the hyperscalers and more muted upside to consumer staples…

“History doesn’t repeat itself, but it often rhymes.”

– (Attributed to) Mark Twain  

The U.S. stock market is starting to look like the spring of 2000 when the dot-com boom came to a halt and technology began a steep slide. At the same time, consumer non-durable (staples) stocks  (as well as Berkshire Hathaway ($BRK.A $BRK.B) have began to perform well both absolutely and relatively.

There are, however, deep differences in both periods of time.

* Today’s large-cap technology stocks (as opposed to the dot-com stocks) have deep moats and though their commitment to massive AI spending has transformed some of the tech equities from capital light to capital intensive, they have maintained  strong operating and profit profiles. Unlike 26 years ago, the Mag 7 represents a large percentage of the indices — which, amid a backdrop of passive products and strategies (ETFs, quants), means that investor inflows go into and directly/steadily support/buoy the shares of Nvidia ($NVDA), Amazon ($AMZN), Microsoft ($MSFT), Alphabet (GOOGL), Micron ($MU), Sandisk (SNDK) and Meta ($META).  

* Today’s defensive consumer staples have faced the competitive threat of generic and unbranded products over the last 15 years. In more recent years, they’ve encountered the introduction of GLP-1 agonists (a new class of medications that can help manage Type 2 diabetes and obesity (by reducing appetite). Unlike 26 years ago, a combination of these two factors are pressuring consumer staples’ top and bottom lines.

As  a result of these differences, the downside to the Mag 7 constituents (and memory and semiconductors) is much more muted than 2 1/2 decades ago (vis a vis dot-com ‘ers). And the upside to the classically defensive consumer non-durables is also more limited than 2 1/2 decades ago.

Importantly, given the rise in the risk-free rate of return (using the 10-year Treasury note) to almost 5.3% suggests to me that rather than find a home in the consumer staples space, it is more likely that market participants will seek refuge in fixed income.

Tactics

Though hyperscalers and semis/memory stocks are beneficiaries of a changed market structure, we own no large-cap tech stocks (and are short some on the periphery of Mag 7) because of our AI reservations and concerns. (See our 260 issues of the  “More Tales From Nvidia” series).

We have previously taken a position in consumer staples — Kimberly-Clark ($KMB), PepsiCo ($PEP), Coca-Cola ($KO) and Procter & Gamble ($PG). But, given the profit threats, we have treated the space more as “trading sardines” and have recently trimmed all four on strength. (Earlier in the week we got lucky and sold the sharp ramp in PEP shares and sold out of the very small balance yesterday on news that KFC has ditched PepsiCo for Coca- Cola.)

Position: Long KMB (VS), KO (VS), PG (VS)

Trading Around a Core Long

I reduced my $PEP long from M to S at $128.15 — taking a couple of points profit out of the trade (over the last two days) in an increasingly uncertain and volatile market.

I definitely plan to reload on weakness ($126ish).

I like the position intermediate term and most who are involved may consider just holding on.

Position: PEP (S) 

Midday Musings

Consumer non-durables (staples) leading the pack today:  $PG, $PEP, $KMB and $KO.

Position: Long PG (VS), PEP (M), KMB (S), KO (VS)